427 related articles for article (PubMed ID: 28325221)
21. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
22. Correction: Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial.
PLOS ONE Staff
PLoS One; 2015; 10(5):e0127719. PubMed ID: 25938465
[No Abstract] [Full Text] [Related]
23. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
Heiligenstein JH; Tollefson GD; Faries DE
J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
Jangid P; Malik P; Singh P; Sharma M; Gulia AK
Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314
[TBL] [Abstract][Full Text] [Related]
25. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
26. Double-blind fluoxetine in depressed alcoholic smokers.
Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease.
Petracca GM; Chemerinski E; Starkstein SE
Int Psychogeriatr; 2001 Jun; 13(2):233-40. PubMed ID: 11495397
[TBL] [Abstract][Full Text] [Related]
28. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
[TBL] [Abstract][Full Text] [Related]
29. Clinician, parent, and child prediction of medication or placebo in double-blind depression study.
Hughes CW; Emslie G; Kowatch R; Weinberg W; Rintelmann J; Rush AJ
Neuropsychopharmacology; 2000 Nov; 23(5):591-4. PubMed ID: 11027925
[TBL] [Abstract][Full Text] [Related]
30. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
Zhang WJ; Yang XB; Zhong BL
J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
[TBL] [Abstract][Full Text] [Related]
31. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
Tollefson GD; Sayler ME
Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
[TBL] [Abstract][Full Text] [Related]
32. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder.
Luo YL; Zhang MY; Wu WY; Li CB; Lu Z; Li QW
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1522-5. PubMed ID: 19733606
[TBL] [Abstract][Full Text] [Related]
33. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
34. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G
Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391
[TBL] [Abstract][Full Text] [Related]
35. Retraction: Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial.
PLOS ONE Editors
PLoS One; 2020; 15(4):e0232415. PubMed ID: 32324840
[No Abstract] [Full Text] [Related]
36. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
37. Homeopathic Treatment of Overweight and Obesity in Pregnant Women With Mental Disorders: A Double-blind, Controlled Clinical Trial.
Vilhena EC; Castilho EA
Altern Ther Health Med; 2016 Oct; 22(S3):14-22. PubMed ID: 27866182
[TBL] [Abstract][Full Text] [Related]
38. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
39. "Wish bias" in antidepressant drug trials?
Barbui C; Cipriani A; Brambilla P; Hotopf M
J Clin Psychopharmacol; 2004 Apr; 24(2):126-30. PubMed ID: 15206658
[TBL] [Abstract][Full Text] [Related]
40. Placebo-controlled treatment trial of depression in elderly physically ill patients.
Evans M; Hammond M; Wilson K; Lye M; Copeland J
Int J Geriatr Psychiatry; 1997 Aug; 12(8):817-24. PubMed ID: 9283926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
